Verona Pharma PLC
NASDAQ:VRNA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Verona Pharma PLC
NASDAQ:VRNA
|
UK |
|
S
|
Spark New Zealand Ltd
F:NZT
|
NZ |
|
C
|
Crocs Inc
XMUN:C7N
|
US |
|
Hermes International SCA
PAR:RMS
|
FR |
|
V
|
Vanquis Banking Group PLC
SWB:PRVA
|
UK |
|
Open House Group Co Ltd
F:O4H
|
JP |
|
CTS Corp
F:XT1
|
US |
|
Epigral Ltd
NSE:EPIGRAL
|
IN |
|
T
|
Trip.com Group Ltd
OTC:TRPCF
|
CN |
|
I
|
IST Ltd
BSE:508807
|
IN |
|
Energy Resources Of Australia Ltd
ASX:ERA
|
AU |
|
F
|
Furukawa Battery Co Ltd
XBER:FBB
|
JP |
|
D
|
Deutsche Telekom AG
OTC:DTEGF
|
DE |
|
Diversified Royalty Corp
TSX:DIV
|
CA |
|
Puregold Price Club Inc
OTC:PGCMF
|
PH |
|
B
|
Befesa SA
DUS:BFSA
|
LU |
|
V
|
Vivendi SE
XMUN:VVU
|
FR |
|
Delivra Health Brands Inc
F:3F0
|
CA |
|
Grenevia SA
F:8MF
|
PL |
Bankruptcy Probability
Verona Pharma PLC's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Verona Pharma PLC Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| UK |
|
Verona Pharma PLC
NASDAQ:VRNA
|
7.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
616.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
320.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
241B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
195.9B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.5T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
218B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Verona Pharma PLC's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Verona Pharma PLC has total debt of 242.4m USD. This includes both short-term (0 USD) and long-term (242.4m USD) debt.
You can find a full breakdown on its Balance Sheet.
